Candesartan CAS 139481-59-7 Tsaftace> 99.0% (HPLC) Factory

Takaitaccen Bayani:

Sunan Chemical: Candesartan

Saukewa: 139481-59-7

Tsafta:> 99.0% (HPLC)

Bayyanar: Farin Foda

Zaɓaɓɓen Angiotensin II Mai karɓar Mai karɓa

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari Candesartan
Makamantu CV-11974;2-Ethoxy-1-[[2'- (1H-tetrazol-5-yl) [1,1'-biphenyl] -4-yl] methyl] -1H-Benzimidazole-7-Carboxylic Acid;3-[[2'- (1H-Tetrazol-5-yl) biphenyl-4-yl] methyl] -2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP Impurity G
Lambar CAS 139481-59-7
Lambar CAT Saukewa: RF-PI1889
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C24H20N6O3
Nauyin Kwayoyin Halitta 440.45
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Farin Foda
Identification-HPLC Lokacin Riƙewa Yayi kama da Ma'auni
Identification-IR Kama da Standard
Tsarkake / Hanyar Bincike > 99.0% (HPLC)
Matsayin narkewa 183.0 ~ 185.0 ℃
Asara akan bushewa <0.50%
Danshi (KF) <0.50%
Ragowa akan Ignition <0.50%
Karfe masu nauyi <20ppm
Rashin Tsabtace Mutum <1.00% (HPLC)
Jimlar ƙazanta <1.00% (HPLC)
Fihirisar Refractive n20/D 1.745~1.747
Matsayin Gwaji Matsayin Kasuwanci
Amfani API;Domin Maganin Hawan Jini

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

Candesartan (CAS: 139481-59-7) antagonist mai karɓar mai karɓar angiotensin II tare da IC50 na 0.26 nM.Manufa: Angiotensin II Receptor candesartan ana nuna shi don maganin hauhawar jini.Candesartan Cilexetil an fara amincewa da shi a cikin GB a ranar 29 ga Afrilu, 1997, sannan Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da ita a ranar 4 ga Yuni, 1998, kuma Hukumar Kula da Magunguna da Magunguna ta Japan (PMDA) ta amince da ita a ranar 12 ga Maris, 1999. AstraZeneca ne ya haɓaka shi, sannan aka tallata shi azaman Atacand ta AstraZeneca a GB da Amurka, kuma Takeda ya tallata shi azaman Blopress a cikin JP.Candesartan Cilexetil shine mai hana mai karɓa na angiotensin II (ARB), yana toshe tasirin vasoconstrictor da aldosterone na angiotensin II ta hanyar zaɓin toshe ɗaurin angiotensin II zuwa mai karɓar AT1 a cikin kyallen takarda da yawa, kamar tsoka mai santsi na jijiyoyin jini da glandar adrenal.Ana nuna Atacand don maganin hauhawar jini a cikin manya da yara 1 zuwa <17 shekaru, rashin ciwon zuciya (NYHA class II-IV) kuma ana amfani dashi don rage mutuwar zuciya da jijiyoyin jini da kuma rashin ciwon zuciya a asibiti.

Ku rubuta sakonku anan ku aiko mana